US intelligence officials inform senators that Chinese pharma giant WuXi Biologics allegedly transferred US IP to Beijing.

US intelligence officials informed senators that Chinese pharma giant WuXi Biologics allegedly transferred US intellectual property to Beijing without authorization. This comes amid concerns that certain Chinese biotech firms are providing research and development for use by the Chinese military. The officials' concerns were based on recent intelligence and involved activities in the US contrary to US national security interests.